Skip to main content

Review of the Fialuridine (FIAU) Clinical Trials (1995) / Chapter Skim
Currently Skimming:

Appendix B: Bibliography and References
Pages 165-177

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 165...
... 1981. Adenine arabinoside therapy in HBsAg positive chronic liver disease: A controlled study.
Read the entire page →
From page 166...
... 1989. Delayed cytotoxicity and selective loss of mitochondrial DNA in cells treated with the anti-human immunodeficiency virus compound 2t,3~-dideoxycytidine.
Read the entire page →
From page 167...
... prophylaxis following liver transplantation (I~tx) (abstract)
Read the entire page →
From page 168...
... 1994a. Adverse experience reporting requirements for human drug and licensed biological products: proposed rules; 21 CFR Part 20, et al.
Read the entire page →
From page 169...
... A.11984. Randomized controlled trial of adenine arabinoside monophosphate for chronic type B hepatitis.
Read the entire page →
From page 170...
... 1993. Cytomegalovirus disease in liver transplant recipients: Impact of acyclovir prophylaxis.
Read the entire page →
From page 171...
... 1993. Ganciclovir prophylaxis decreases frequency and severity of cytomegalovirus disease in seropositive liver transplant recipients treated with OKT3 monoclonal antibodies.
Read the entire page →
From page 172...
... 1993. High-dose oral acyclovir reduces the incidence of cytomegalovirus infection in liver transplant recipients.
Read the entire page →
From page 173...
... 1992. Evaluation of three cytomegalovirus infection prophylactic regimens in liver transplant recipients.
Read the entire page →
From page 174...
... 1993. Randomized controlled trial of acyclovir for the prevention of cytomegalovirus infection and disease in liver transplant recipients.
Read the entire page →
From page 175...
... A pilot open-labeled Phase II study using oral ribavirin in the treatment of patients with chronic active hepatitis B Clinical and Diagnostic Virology.
Read the entire page →
From page 176...
... 1982. Successful treatment of HBsAg and HBeAg positive chronic liver disease: Prolonged inhibition of viral replication by highly soluble adenine arabinoside 5' monophosphate (ARA-AMP)
Read the entire page →
From page 177...
... 1983. Phase 1 evaluation of 2'fluoro-5-iodo1-beta-D-arabinofuranosylcytosine in immunosuppressed patients with herpesvirus infection.
Read the entire page →

Key Terms

  • clinical trials
  • virus infection
  • clinical pharmacology
  • adenine arabinoside
  • infectious disease

  • medical journal
  • antimicrobial agents
  • chronic type
  • controlled trial
  • summary sheets

  • liver transplant
  • patient summary
  • response letter
  • transplant recipients
  • fda warning

  • british medical
  • eli lilly
  • mitochondrial dna
  • chronic active
  • active hepatitis

  • adverse reactions
  • leukocyte interferon
  • cytomegalovirus disease
  • immunodeficiency virus
  • randomized controlled

  • immunodeficiency syndrome
  • acquired immunodeficiency
  • human leukocyte
  • cytomegalovirus infection
  • prednisone withdrawal


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.